3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
2
Active not recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
1
NET
1
Endocrine
1
Conditions
Small Cell Lung Carcinoma
1
Neuroendocrine Tumors
1
Neoplasms
1
Interventions
pembrolizumab
84
Specimen Handling
79
Carboplatin
74
Magnetic Resonance Spectroscopy
71
Biopsy
58
Nivolumab
55
Cisplatin
55
Paclitaxel
46
Cyclophosphamide
44
durvalumab
37
Radiotherapy
36
Radiation
35
Rituximab
34
olaparib
33
Etoposide
33
Dexamethasone
33
Ipilimumab
30
Gemcitabine
30
Lenalidomide
28
Taxes
27
Pemetrexed
27
Doxorubicin
27
Docetaxel
27
Bevacizumab
24
Prednisone
23
Cytarabine
23
X-Rays
22
Trastuzumab
21
cabozantinib
20
Disulfides
20
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Active not recruiting
×
Has results
×
AMG 757
×
Clear all
NCT06502977
2026-04-15
DeLLphi-307
Amgen
Phase 2
Active not recruiting
32 enrolled
9 charts
NCT05740566
2026-01-05
DeLLphi-304
Amgen
Phase 3
Active not recruiting
509 enrolled
11 charts
1 FDA